Edris Badreddin
SEC insider (Form 3/4/5 filer). CIK 0001786966. Director at Edgewise Therapeutics, Inc. (EWTX) and 1 other issuer. 28 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in BOULDER, CO.
Companies Edris Badreddin has filed insider reports for
- Edgewise Therapeutics, Inc. (EWTX): Director
- SpringWorks Therapeutics, Inc. (SWTX): Officer, Chief Operating Officer
Edris Badreddin
CIK: 0001786966
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Jun 5, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectRestricted Stock Units
5.6K shares- - Jun 5, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
8.2K shares- - Jan 21, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect7.6K shares at avg. $29.44$224K - Jan 21, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect7.6K shares at avg. $0.71$5K - Jan 21, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect66.5K shares at avg. $1.93$128K - Jan 21, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect17.2K shares at avg. $29.44$507K - Jan 21, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect17.2K shares at avg. $0.64$11K - Jan 21, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect10.5K shares at avg. $1.93$20K - Jan 21, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect13.7K shares at avg. $0.39$5K - Jan 21, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect13.7K shares at avg. $29.44$403K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  EWTX Edgewise Therapeutics, Inc. | Award Restricted Stock Units | 5,619 | - | - | Direct |
| Jun 5, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 8,188 | - | - | Direct |
| Jan 21, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 7,605 | $29.44 | $223,891 | Direct |
| Jan 21, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 7,605 | $0.71 | $5,400 | Direct |
| Jan 21, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 66,477 | $1.93 | $128,301 | Direct |
| Jan 21, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 17,236 | $29.44 | $507,428 | Direct |
| Jan 21, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 17,236 | $0.64 | $11,031 | Direct |
| Jan 21, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 10,463 | $1.93 | $20,194 | Direct |
| Jan 21, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 13,690 | $0.39 | $5,339 | Direct |
| Jan 21, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 13,690 | $29.44 | $403,034 | Direct |
1-10 of 28 transactions